Skip to main contentAI and Advanced
/
ASTEC · NSEMarket ticker unavailable · configure an authorised index feed
AS
NSE · Equity shares · Chemical Manufacturing3.90 · 0.59%
Astec LifeSciences ASTEC
NSE:INR 668.9
BSE:INR 670.7
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for ASTEC
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 665
Day rangeINR 640.55 — INR 673.6
52-week rangeINR 513.4 — INR 941.75
Volume34,108
Market cap1,496.04
P/ENot available
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)448.15
Net Income (INR Cr)-80.92
Rev Growth (5 Year %)-4.18
Book Value164.19
EPS-37.13
Price/BV4.07Computed
Research path: Interpret Astec LifeSciences's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
ASTECAstec LifeSciences1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 942.04 | 881.42 | 974.93 |
| Accumulated Depreciation Total | -286.97 | -242.96 | -199.63 |
| Other Liabilities Total | 1.3 | 0.66 | 2.49 |
| Accrued Expenses | 0.56 | 0.51 | 0.4 |
| Long Term Debt | 50 | 280 | 199 |
| Common Stock Total | 22.28 | 19.61 | 19.61 |
| Other Equity Total | -0.01 | 0.01 | 0.01 |
| Other Current Assets Total | 2.77 | 2.41 | 2.17 |
| Prepaid Expenses | 3.92 | 4.68 | 5.01 |
| Total Assets | 942.04 | 881.42 | 974.93 |
| Current Portof LT Debt/Capital Leases | 89.06 | 10.18 | 11.94 |
| Additional Paid-In Capital | 295.03 | 61.39 | 61.09 |
| Cash | 10.05 | 0.58 | 0.47 |
| Total Equity | 390.61 | 234.75 | 369.29 |
| Long Term Investments | 0.01 | 0.01 | 0.01 |
| Retained Earnings(Accumulated Deficit) | 73.19 | 153.62 | 288.2 |
| Total Common Shares Outstanding | 2.23 | 1.98 | 1.98 |
| Property/Plant/Equipment Total-Gross | 740.8 | 739.66 | 731.21 |
| Tangible Book Valueper Share Common Eq | 164.19 | 106.92 | 177.07 |
| Total Liabilities | 551.43 | 646.68 | 605.64 |
| Total Debt | 448.93 | 554.54 | 493.89 |
| Cashand Short Term Investments | 10.05 | 0.58 | 0.47 |
| Total Receivables Net | 285.94 | 171.51 | 193.69 |
| Notes Payable/Short Term Debt | 309.87 | 264.37 | 282.96 |
| Deferred Income Tax | 0.04 | 0.04 | 6.76 |
| Accounts Receivable-Trade Net | 247.72 | 147.52 | 169.07 |
| Property/Plant/Equipment Total-Net | 453.83 | 496.7 | 531.58 |
| Minority Interest | 0.31 | 0.27 | 0.23 |
| Total Current Liabilities | 499.79 | 365.71 | 397.16 |
| Total Inventory | 140.32 | 161.96 | 197.16 |
| ESOP Debt Guarantee | 0.12 | 0.11 | 0.38 |
| Accounts Payable | 87.67 | 81.61 | 89.28 |
| Other Currentliabilities Total | 12.63 | 9.05 | 12.58 |
| Total Long Term Debt | 50 | 280 | 199 |
| Intangibles Net | 24.75 | 23.45 | 19.42 |
| Other Long Term Assets Total | 1.35 | 1.36 | 1.73 |
| Note Receivable-Long Term | 19.11 | 18.77 | 23.71 |
| Total Current Assets | 442.99 | 341.14 | 398.49 |
Fundamentals
Valuation and ratios
Growth
Debt 5Yr CAGR %19.12
Margins
Operating Margin 12m-11.5
Operating Margin 5y Avg-1.57
Net Profit Margin 12m-18.05
Net Profit Margin 5y-5.67
Yield
Dividend Yield %0
Valuation
Price to Sale Ratio3.34
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskHigh risk
Board Risk56.93
Analyst consensus
ConsensusSell
Consensus score4.00
Analyst opinions1
Strong Sell count0
Sell count1
Hold count0
Buy count0
Strong Buy count0
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Asian Paints | INR 2,690.2 | 2.58 L | 58.14 | — |
| Solar Industries India | INR 18,921.6 | 1.71 L | 102.64 | — |
| Pidilite Industries | INR 1,573.95 | 1.60 L | 64.75 | — |
| SRF | INR 2,865 | 85,167.59 | 44.53 | — |
| Linde India | INR 6,895 | 58,803.47 | 108.69 | — |
Shareholding
Ownership
- Promoter
- 71.96%
- FII
- 0.01%
- MF
- 3.02%
- Other
- 25.01%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Jubilant FoodWorks: Nippon India MF ची मोठी खरेदी! कंपनीतील हिस्सेदारी वाढवली - WhalesbookMarket news · 14 Jul 2026, 4:29 pm
Jubilant FoodWorks: Nippon India MF ची मोठी खरेदी! कंपनीतील हिस्सेदारी वाढवली Whalesbook
Astec Lifesciences Ltd is Rated Sell by MarketsMOJO - MarketsMojoMarket news · 12 Jul 2026, 11:16 pm
Astec Lifesciences Ltd is Rated Sell by MarketsMOJO MarketsMojo
Astec LifeSciences Schedules 32nd AGM on July 31, 2026; Reports Revenue Recovery in FY 2025-26 - scanx.tradeMarket news · 9 Jul 2026, 5:02 pm
Astec LifeSciences Schedules 32nd AGM on July 31, 2026; Reports Revenue Recovery in FY 2025-26 scanx.trade
Astec Lifesciences Turns EBITDA Positive, Reduces Net Loss in FY26 - WhalesbookMarket news · 8 Jul 2026, 8:18 pm
Astec Lifesciences Turns EBITDA Positive, Reduces Net Loss in FY26 Whalesbook
Astec LifeSciences announces 32nd AGM and book closure dates - BusinessUpturnMarket news · 8 Jul 2026, 8:11 pm
Astec LifeSciences announces 32nd AGM and book closure dates BusinessUpturn
Astec LifeSciences announces 32nd AGM and closure of share transfer books - BusinessUpturnMarket news · 8 Jul 2026, 7:42 pm
Astec LifeSciences announces 32nd AGM and closure of share transfer books BusinessUpturn
Corporate actions
Events
- annual General MeetingAGM
- annual General MeetingPOM
- board MeetingsAudited Results
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
- rightsRights issue of equity shares of Rs. 10/- in the ratio of 1:7 @ premium of Rs. 880/-.
Rusaka Markets Community
Discussion and sentiment for Astec LifeSciences
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Astec LifeSciences Limited is an India-based company, which is engaged in the manufacturing of agrochemical active ingredients (technical), bulk, formulations and intermediate products. The Company undertakes contract development and manufacturing services for a diverse range of agrochemicals. The Company operates through a single segment, namely Agrochemicals. Its product categories include Fungicide, Growth Regulator, Intermediates, Insecticide, and Herbicide. Its products include Azimsulfuron, Halosulfuron, Flutriafol, Rimsulfuron, Transfluthrin, Prothiaconazole, Metalaxyl, Cyproconazole, and Tribenuron methyl. It has a sales mix of both exports and domestic sales. It exports to approximately 17 countries, including the United States and countries across Europe, West Asia, South-East Asia, Latin America and Africa. The Company has approximately nine manufacturing plants, which are located in Maharashtra.
Company facts
- Industry
- Chemical Manufacturing
- Sector
- Chemical Manufacturing
- NSE Code
- ASTEC
- BSE Code
- 533138
Questions
Stock FAQ
What is the symbol and ISIN of Astec LifeSciences?
Astec LifeSciences has the symbol ASTEC and ISIN - INE563J01010.
What is the current price of Astec LifeSciences?
Astec LifeSciences is currently trading at INR 668.90.
What are the year high and year low of Astec LifeSciences?
Astec LifeSciences has a year high of INR 941.75 and a year low of INR 513.40.
What is the market capitalization of Astec LifeSciences?
Astec LifeSciences has a market capitalization of INR 1,496.04 crore.
What is the P/E ratio of Astec LifeSciences?
Astec LifeSciences has a P/E ratio of NA.
What is the dividend yield of Astec LifeSciences?
Astec LifeSciences has a dividend yield of 0.00%.
How is the financial performance of Astec LifeSciences based on revenue, net income, and EPS?
Astec LifeSciences has revenue of INR 448.15 crore, net income of INR -80.92 crore, and EPS of INR -37.98.
What is the book value of Astec LifeSciences?
Astec LifeSciences has a book value of INR 164.19.
What is the debt-to-equity ratio of Astec LifeSciences?
Astec LifeSciences has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Astec LifeSciences?
Astec LifeSciences has a price-to-book ratio of 4.07 and a price-to-sales ratio of 3.34.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.